Akti-1/2

Name: Akti-1/2
Brand: Tocris Bioscience
SKU: 5773
Rating: 4.5 (2 reviews)

Cat. No. 5773 11 Citations 2 Reviews Submit a Review Datasheet / COA / SDS

Pricing	Availability		Qty

Bulk Orders

Request a Quote

Description: Potent and selective dual Akt1 and 2 inhibitor

Alternative Names: Akt Inhibitor VIII

Chemical Name: 1,3-Dihydro-1-[1-[[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl]methyl]-4-piperidinyl]-2H-benzimidazol-2-one

Purity: ≥98% (HPLC)

Datasheet

Citations (11)

Reviews (2)

Literature (1)

Pathways (1)

Biological Activity Technical Data Solubility Calculators Datasheets References

Biological Activity for Akti-1/2

Akti-1/2 is a potent and selective dual Akt1 and 2 inhibitor (IC₅₀ values are 50 and 210 nM, respectively). Selective for Akt1 and 2 over a panel of other tyrosine and serine/threonine kinases. Sensitizes LnCaP cells to TRAIL (TNF-related apoptosis-inducing ligand) induced apoptosis. Also enhances CAR and TCR retroviral transduction of human T cells. Active in vivo.

Technical Data for Akti-1/2

M. Wt	551.64
Formula	C₃₄H₂₉N₇O
Storage	Store at -20°C
Purity	≥98% (HPLC)
CAS Number	612847-09-3
PubChem ID	10196499
InChI Key	BIWGYFZAEWGBAL-UHFFFAOYSA-N
Smiles	O=C1NC2=C(C=CC=C2)N1C(CC3)CCN3CC(C=C4)=CC=C4C5=NC6=CC(N=CN7)=C7C=C6N=C5C8=CC=CC=C8

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility Data for Akti-1/2

	Solvent	Max Conc. mg/mL	Max Conc. mM
Solubility
Solubility	DMSO	11.03	20 with gentle warming

Preparing Stock Solutions for Akti-1/2

The following data is based on the product molecular weight 551.64. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
0.2 mM	9.06 mL	45.32 mL	90.64 mL
1 mM	1.81 mL	9.06 mL	18.13 mL
2 mM	0.91 mL	4.53 mL	9.06 mL
10 mM	0.18 mL	0.91 mL	1.81 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

Mass

Concentration

Volume

M. Wt* g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution.

Concentration 1

Volume 1

Concentration 2

Volume 2

Product Datasheets for Akti-1/2

Certificate of Analysis / Product Datasheet

Safety Datasheet

References for Akti-1/2

References are publications that support the biological activity of the product.

DeFeo-Jones D et al (2005) Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family members. Mol.Cancer Ther. 4 271 PMID: 15713898

Barnett et al (2005) Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors. Biochem. J. 385 399 PMID: 15456405

Lindsley et al (2005) Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors. Bioorg.Med.Chem.Lett. 15 761 PMID: 15664853

Bain et al (2007) The selectivity of protein kinase inhibitors: a further update. Biochem.J. 408 297 PMID: 17850214

Klebanoff et al (2017) Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy. JCI Insight 2 e95103 PMID: 29212954

If you know of a relevant reference for Akti-1/2, please let us know.

View Related Products by Target

View Related Products by Product Action

View all Akt (Protein Kinase B) Inhibitors

Keywords: Akti-1/2, Akti-1/2 supplier, Akt1/2, inhibitors, inhibits, potent, selective, PKB, protein, kinase, B, sensitizes, apoptosis, viral, transduction, enhancer, enhances, Akt, Inhibitor, VIII, (Protein, Kinase, B), Protein, B/Akt, Viral, Transduction, Enhancers, 5773, Tocris Bioscience

11 Citations for Akti-1/2

Citations are publications that use Tocris products. Selected citations for Akti-1/2 include:

Claudio et al (2022) PD-1-induced T cell exhaustion is controlled by a Drp1-dependent mechanism. Mol Oncol 16 188-205 PMID: 34535949

Aurélie et al (2022) Exosomes from EGFR-Mutated Adenocarcinoma Induce a Hybrid EMT and MMP9-Dependant Tumor Invasion. Cancers (Basel) 14 PMID: 35954442

Lucie et al (2022) Regulation of Stress-Activated Kinases in Response to Tacaribe Virus Infection and Its Implications for Viral Replication. Viruses 14 PMID: 36146824

Adriano et al (2022) TSC22D4 interacts with Akt1 to regulate glucose metabolism. Sci Adv 8 eabo5555 PMID: 36269831

Margitta et al (2022) Pannexin-1 Activation by Phosphorylation Is Crucial for Platelet Aggregation and Thrombus Formation. Int J Mol Sci 23 PMID: 35563450

Viviana I et al (2019) Wnt-induced activation of glucose metabolism mediates the in vivo neuroprotective roles of Wnt signaling in Alzheimer disease. J Neurochem 149 54-72 PMID: 30300917

Kodaka et al (2020) Characterization of a novel compound that promotes myogenesis via Akt and transcriptional co-activator with PDZ-binding motif (TAZ) in mouse C2C12 cells. PLoS One 15 e0231265 PMID: 32267872

Perkins et al (2018) Autocrine-paracrine prostaglandin E₂ signaling restricts TLR4 internalization and TRIF signaling. Nat.Immunol. 19 1309 PMID: 30397349

Zhong et al (2018) Tyro3 is a podocyte protective factor in glomerular disease. JCI Insight 3 PMID: 30429374

Anna M et al (2021) Gαq activation modulates autophagy by promoting mTORC1 signaling. Nat Commun 12 4540 PMID: 34315875

Charles G et al (2021) EGFR Activates a TAZ-Driven Oncogenic Program in Glioblastoma. Cancer Res 81 3580-3592 PMID: 33910930

Do you know of a great paper that uses Akti-1/2 from Tocris? Please let us know.

Reviews for Akti-1/2

Average Rating: 4.5 (Based on 2 Reviews.)

5 Star

50%

4 Star

50%

3 Star

2 Star

1 Star

Have you used Akti-1/2?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:

Akti-1/2 blocks LPA-mediated COX-2 expression.

By Peter Cruz on 12/13/2018

Assay Type: In Vitro

Species: Human

Cell Line/Tissue: Osteosarcoma

Human osteosarcoma cells were incubated with 10 μM Akti-1/2 for 30 min prior to treatment with 10 μM LPA to estimate COX-2 expression using Western blot analysis. Akti-1/2 abolished LPA-induced COX-2 expression.

Akt-1/2 blocks 15d-PGJ2-induced Akt phosphorylation.

By Christopher Trummer on 10/15/2018

Assay Type: In Vitro

Species: Human

Cell Line/Tissue: MG-63 osteosarcoma cells

MG-63 cells were incubated with PD169316 (25 μM), LY294002 (10 μM) or Akt-1/2 (5 μM Akt-I) for 30 min prior to 15d-PGJ2 treatment (20 μM) for 1 h to follow pAkt expression using Western blot. Akt-1/2 completely blocked 15d-PGJ2-induced Akt phosphorylation in MG-63 cells.

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.

Cancer Research Product Guide

A collection of over 750 products for cancer research, the guide includes research tools for the study of:

Cancer Metabolism
Epigenetics in Cancer
Receptor Signaling
Cell Cycle and DNA Damage Repair
Angiogenesis
Invasion and Metastasis

Pathways for Akti-1/2

Akt Signaling Pathway

The Akt signaling pathway plays a key role in the mediation of protein synthesis, metabolism, proliferation and cell cycle progression. It may be referred to as a 'prosurvival' pathway.